E-LIB Suche - Ergebnisse für: Grünwald, V.

1

Loss of membranous NECTIN-4 occurs frequently during metast..:

Klümper, N. ; Ralser, D.J. ; Ellinger, J....
European Urology. 83 (2023) - p. S772-S773 , 2023

Link: https://doi.org/10.1016/..

2

Real world evidence from a retrospective multi-center analy..:

Materna, L. ; Schlack, K. ; Stelmach, R....
European Urology Open Science. 57 (2023) - p. S226-S227 , 2023

Link: https://doi.org/10.1016/..

3

Real-world clinical data and gene expression analysis of ur..:

Szarvas, T. ; Varadi, M. ; Horvath, O....
European Urology Open Science. 56 (2023) - p. S13 , 2023

Link: https://doi.org/10.1016/..

4

First-line therapy of treatment-naive advanced or metastati..:

Rexer, H. ; Grünwald, V. ; Doehn, C.
Forum. 38 (2023) 2 - p. 149-151 , 2023

Link: https://doi.org/10.1007/..

5

Tumor Response by Baseline Metastases in Patients (Pts) Wit..:

Grünwald, V. ; McKay, R.R. ; Buchler, T....
European Urology Open Science. 57 (2023) - p. S15-S16 , 2023

Link: https://doi.org/10.1016/..

6

IO-Synthesise RCC: relationship between baseline health-rel..:

Bedke, J. ; Thiery-Vuillemin, A. ; Grimm, M.O....
European Urology Open Science. 57 (2023) - p. S258-S259 , 2023

Link: https://doi.org/10.1016/..

7

Lenvatinib plus Pembrolizumab as first-line treatment in pa..:

Stelmach, R. ; Schlack, K. ; Neuberger, S....
European Urology Open Science. 57 (2023) - p. S219-S220 , 2023

Link: https://doi.org/10.1016/..

8

Introduction of dual checkpoint inhibition with nivolumab p..:

Derigs, M. ; Niegisch, G. ; Richter, T.R....
European Urology. 83 (2023) - p. S487 , 2023

Link: https://doi.org/10.1016/..

9

On-treatment modified Glasgow prognostic score (mGPS) impro..:

Saal, J. ; Bald, T. ; Eckstein, M....
European Urology. 83 (2023) - p. S483 , 2023

Link: https://doi.org/10.1016/..

10

Kombinierte Hormontherapie beim lokal begrenzten Prostataka..:

Ohlmann, Carsten ; Grünwald, V. ; Hadaschik, B.
Der Urologe. , 2022

Link: https://doi.org/10.1007/..

11

Impact of subsequent therapies in patients (pts) with advan..:

Voss, M.H. ; Powles, T. ; Mcgregor, B....
European Urology Open Science. 45 (2022) - p. S197-S198 , 2022

Link: https://doi.org/10.1016/..

12

Die Behandlung von Kopf-Hals-Tumoren wird zunehmend komplex..:

Dietz, A. ; Rau, A. ; Hoffmann, J....
Forum. 37 (2022) 2 - p. 146-150 , 2022

Link: https://doi.org/10.1007/..

13

Systemic therapy in metastatic renal cell carcinoma (mRCC):..:

Grünwald, V. ; Bergmann, L. ; Brehmer, B....
World Journal of Urology. 40 (2022) 10 - p. 2381-2386 , 2022

Link: https://doi.org/10.1007/..

14

PREPARE – Phase-III-Studie zur Erstlinientherapie des unbeh..:

Rexer, H. ; Grünwald, V. ; Doehn, C.
Forum. 36 (2021) 3 - p. 253-255 , 2021

Link: https://doi.org/10.1007/..

15

The prognostic value of serum MMP-7 levels in prostate canc..:

Szarvas, T. ; Csizmarik, A. ; Váradi, M....
Urologic Oncology: Seminars and Original Investigations. 39 (2021) 5 - p. 296.e11-296.e19 , 2021

Link: https://doi.org/10.1016/..